10.1042/BST20200270 Summary Keywords GLP-1, immunemetabolic signaling, metabolic disease, neuroendocrine peptides, orphan receptors, peptide therapeutics, polypharmacology Citation Niazi SK (2026) Beyond GLP-1: underexplored peptidereceptor systems as the next frontier in drug discovery
Therefore, therapeutic options that could work in a way other than classic antidepressants are being sought to increase the effectiveness of the treatment
Patients should not assume that online products labeled retatrutide, research peptide, or triple agonist are safe, legitimate, accurately dosed, or medically appropriate
Your current weight
Amir reviews your medical history, labs, and goals to tailor a safe GLP1 plan
Adding it to the mix might create yet another additive or synergistic benefit